Dark Horse Consulting Announces Expansion of Quality and Device Engineering Teams

Campbell, CA, April 2018 — Dark Horse Consulting (DHC), a leading provider of consulting services for the cell and gene therapy industry, today announced the appointments of Christine Bui as Senior Consultant and Vince So as Consultant. Christine Bui has been a part time Associate Consultant at DHC for the past 18 months, advising cell

Dark Horse Consulting Announces Appointment of Katy Spink, Ph.D. as Managing Partner

Campbell, CA, January 22, 2018 — Dark Horse Consulting, a leading provider of consulting services for the cell and gene therapy industry, today announced the appointment of Katy Spink, Ph.D. as a Managing Partner of the firm. Dr. Spink will join Anthony Davies, Ph.D., CEO and Founder, and Felicity Martin, CPA, Senior Director of Finance

TrakCel Brings in New Director

Cardiff-headquartered TrakCel, which develops software for cell and gene therapy companies, has appointed a new director.

Dr. Anthony Davies, from Dark Horse Consulting, has been recruited as a non-executive director.

CellGenix Appoints Leading Experts to Scientific Advisory Board

CellGenix, a global leader in providing GMP-grade raw materials for cell and gene therapy and tissue-engineered products, today announced the appointment of highly experienced and internationally respected experts in the field of cell and gene therapy to its Scientific Advisory Board (SAB). The SAB will serve as a strategic resource to CellGenix as it continues